Skip to main navigation Skip to search Skip to main content

A Phase 3, Open-Lable, Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia

Project: Research

Project Details

StatusFinished
Effective start/end date08/3/15 → 08/2/18

Funding

  • Neurocrine Biosciences Incorporated: $7,500.00